The financials
Zoetis by the numbers
Zoetis (ZTS) reported revenue of $2.47B in Q2 2026 (quarter ended June 30, 2026), down 0.2% from the same quarter a year earlier. That came with a gross margin of 73% and net income of $691M (28% of revenue). For the full year FY2025, revenue was $9.47B (+2.3% year on year) and net income $2.67B. Its largest product in 2026-Q1 was Cattle at $392M, 18% of the disclosed total, just ahead of Dermatology at 16%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.47B | $2.47B | −0.2% |
| Gross profit | $1.79B | $1.81B | −0.8% |
| Net income | $691M | $726M | −4.8% |
| Diluted EPS | $1.65 | $1.63 | +1.2% |
| Product | Revenue | Share |
|---|---|---|
| Cattle | $392M | 18% |
| Dermatology | $349M | 16% |
| Anti Infective Products | $241M | 11% |
| Livestock | $225M | 10% |
| Pain Sedation | $203M | 9.3% |
| Other Pharmaceuticals | $158M | 7.3% |
| Swine | $123M | 5.6% |
| Poultry | $118M | 5.4% |
| Animal Health Diagnostics | $117M | 5.4% |
| Horses | $76M | 3.5% |
| Fish | $66M | 3.0% |
| Other Non Pharmaceuticals | $66M | 3.0% |
| Contract Manufacturingand Human Health Diagnostics | $23M | 1.1% |
| Manufactured Product Other | $21M | 1.0% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $2.18B (-8.6%)
Fish grew +20% year on yearContract Manufacturing and Human Health Diagnostics -23% year on year
Segment Latestquarter on quarteryear on year
- Cattle$392.0M$392.0MQoQ -1.8%year on year +15%-1.8%+15%
- Dermatology$349.0M$349.0MQoQ -26%year on year -7.9%-26%-7.9%
- Anti Infective Products$241.0M$241.0MQoQ -15%year on year +1.3%-15%+1.3%
- Livestock$225.0M$225.0MQoQ -11%year on year +7.1%-11%+7.1%
- Pain Sedation$203.0M$203.0MQoQ -0.49%year on year -1.9%-0.49%-1.9%
- Other Pharmaceuticals$158.0M$158.0MQoQ -11%year on year 0.00%-11%0.00%
- Swine$123.0M$123.0MQoQ +11%year on year +17%+11%+17%
- Poultry$118.0M$118.0MQoQ +11%year on year +11%+11%+11%
- Animal Health Diagnostics$117.0M$117.0MQoQ +6.4%year on year +13%+6.4%+13%
- Horses$76.0M$76.0MQoQ +15%year on year +19%+15%+19%
- Fish$66.0M$66.0MQoQ -15%year on year +20%-15%+20%
- Other Non Pharmaceuticals$66.0M$66.0MQoQ +3.1%year on year -7.0%+3.1%-7.0%
- Contract Manufacturing and Human Health Diagnostics$23.0M$23.0MQoQ 0.00%year on year -23%0.00%-23%
- Manufactured Product Other$21.0M$21.0MQoQ -32%year on year +5.0%-32%+5.0%
- Medicated Feed Additives--QoQ -year on year ---
Drug Manufacturers - Specialty & Generic
Ranks #5 of 28 by Smart Score